XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information (Tables)
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Schedule of Net Sales and Operating Results by Segment
The following tables set forth our operating results by segment:
Three Months Ended September 30,
20222021
HealthcareIndustrialConsolidatedHealthcareIndustrialConsolidated
(in thousands)
Revenue$64,203 $68,050 $132,253 $76,365 $79,731 $156,096 
Cost of sales39,547 40,036 79,583 44,735 47,046 91,781 
Gross profit24,656 28,014 52,670 31,630 32,685 64,315 
Less:
Segment operating expenses18,151 21,442 39,593 22,576 19,487 42,063 
Segment operating income$6,505 $6,572 13,077 $9,054 $13,198 22,252 
General corporate expense, net(a)
46,782 39,460 
Operating (loss)$(33,705)$(17,208)

Nine Months Ended September 30,
20222021
HealthcareIndustrialConsolidatedHealthcareIndustrialConsolidated
(in thousands)
Revenue$200,295 $205,004 $405,299 $231,712 $233,057 $464,769 
Cost of sales124,309 121,387 245,696 127,600 139,609 267,209 
Gross profit75,986 83,617 159,603 104,112 93,448 197,560 
Less:
Segment operating expenses52,908 68,296 121,204 53,012 57,770 110,782 
Segment operating income$23,078 $15,321 38,399 $51,100 $35,678 86,778 
General corporate expense, net(a)
127,374 116,005 
Operating (loss)$(88,975)$(29,227)
a.General corporate expense, net includes expenses not specifically attributable to our segments for functions such as human resources, finance, legal and information technology, including salaries, benefits, and other related costs, company-wide incentive compensation and stock-based compensation.